| |
| |
|
| Insider
Information: |
Lundbeckfond Invest A/s |
| Relationship: |
10% Owner |
| City: |
Copenhagen |
| State: |
G7 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
23,300,580 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
23,300,580 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Celladon Corp |
CLDN |
10% Owner |
2014-02-04 |
1,745,683 |
2014-02-04 |
0 |
Premium* |
|
|
Scpharmaceuticals Inc. |
SCPH |
10% Owner |
2017-11-21 |
3,183,986 |
2017-11-21 |
0 |
Premium* |
|
|
Trevi Therapeutics, Inc. |
TRVI |
10% Owner |
2019-05-09 |
1,151,544 |
2019-05-09 |
0 |
Premium* |
|
|
Enliven Therapeutics Ord Shs |
ELVN |
10% Owner |
2020-03-16 |
1,432,722 |
2020-03-16 |
0 |
Premium* |
|
|
Io Biotech, Inc. |
IOBT |
|
2023-08-09 |
13,950,686 |
2021-11-09 |
0 |
Premium* |
|
|
Lexeo Therapeutics, Inc. |
LXEO |
10% Owner |
2023-11-07 |
1,835,959 |
2023-11-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LXEO |
Lexeo Therapeutics, Inc. |
10% Owner |
– – • |
2023-11-07 |
4 |
B |
$11.00 |
$2,499,992 |
D/D |
227,272 |
1,835,959 |
2.45 |
- |
|
| LXEO |
Lexeo Therapeutics, Inc. |
10% Owner |
– – • |
2023-11-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,608,687 |
1,608,687 |
0 |
- |
|
| IOBT |
Io Biotech, Inc. |
|
• • • |
2023-08-09 |
4 |
A |
$1.90 |
$15,012,345 |
D/D |
7,901,234 |
13,950,686 |
0 |
- |
|
| IOBT |
Io Biotech, Inc. |
|
• • • |
2021-11-09 |
4 |
B |
$14.00 |
$29,999,998 |
D/D |
2,142,857 |
6,049,452 |
0.01 |
- |
|
| IOBT |
Io Biotech, Inc. |
|
• • • |
2021-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
3,906,595 |
3,906,595 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2020-03-16 |
4 |
B |
$16.00 |
$3,000,000 |
D/D |
187,500 |
1,432,722 |
2.45 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2020-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,245,222 |
1,245,222 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
10% Owner |
– – • |
2019-05-09 |
4 |
B |
$10.00 |
$3,750,000 |
D/D |
375,000 |
1,151,544 |
2.45 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
10% Owner |
– – • |
2019-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
776,544 |
776,544 |
0 |
- |
|
| SCPH |
Scpharmaceuticals Inc. |
10% Owner |
– – • |
2017-11-21 |
4 |
B |
$14.00 |
$9,166,668 |
D/D |
654,762 |
3,183,986 |
2.45 |
- |
|
| SCPH |
Scpharmaceuticals Inc. |
10% Owner |
– – • |
2017-11-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,529,224 |
2,529,224 |
0 |
- |
|
| CLDN |
Celladon Corp |
10% Owner |
– – • |
2014-02-04 |
4 |
B |
$8.00 |
$1,461,448 |
D/D |
182,681 |
1,745,683 |
2.45 |
- |
|
| CLDN |
Celladon Corp |
10% Owner |
– – • |
2014-02-04 |
4 |
A |
$0.00 |
$148,840 |
D/D |
1,563,002 |
1,563,002 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
